Optic nerve sheath meningioma
Optic Nerve Sheath Meningioma
Optic nerve sheath meningioma (ONSM) is a type of meningioma that arises from the meninges surrounding the optic nerve. It is a rare, benign tumor that can lead to progressive vision loss due to its location and effects on the optic nerve.
Pathophysiology
ONSM originates from the arachnoid cap cells of the meninges, which are the protective coverings of the central nervous system. These tumors are typically slow-growing and can cause compression of the optic nerve, leading to visual disturbances. The compression can result in optic atrophy and eventual loss of vision if not treated.
Clinical Presentation
Patients with optic nerve sheath meningioma often present with progressive, painless vision loss in one eye. Other symptoms may include proptosis (bulging of the eye), diplopia (double vision), and optic disc swelling.
Diagnosis
The diagnosis of ONSM is primarily made through imaging studies. Magnetic resonance imaging (MRI) is the preferred method, as it provides detailed images of the optic nerve and surrounding structures. On MRI, ONSM typically appears as a tubular thickening around the optic nerve.
Treatment
The management of optic nerve sheath meningioma depends on the size and location of the tumor, as well as the degree of vision loss. Observation may be appropriate for small, asymptomatic tumors. However, for tumors causing significant vision loss, treatment options include radiation therapy and, in some cases, surgical intervention.
Radiation therapy, particularly stereotactic radiosurgery, is often the treatment of choice for ONSM, as it can effectively control tumor growth and preserve vision.
Prognosis
The prognosis for patients with optic nerve sheath meningioma varies. Early detection and treatment are crucial for preserving vision. While the tumor itself is benign, its location can lead to significant morbidity if not managed appropriately.
Related Pages
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD